by Lori Solomon The U.S. Food and Drug Administration has approved Merck’s Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults. Capvaxive is specifically designed to help protect adults against the serotypes that cause the majority of invasive pneumococcal disease cases, including Streptococcus pneumoniae serotypes 3, 6A,...
Tag: <span>pneumococcal</span>
Post
Pneumococcal vaccine recs cause confusion among docs
(HealthDay)—While primary care physicians overwhelmingly recommend pneumococcal vaccines, there is a gap in their knowledge of how to implement related vaccine recommendations, according to a study published in the Journal of the American Board of Family Medicine. Laura P. Hurley, M.D., M.P.H., from the University of Colorado Anschutz Medical Campus in Aurora, and colleagues conducted...